v3.24.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 6,497 $ 6,526
Fixed maturity securities (amortized cost of $29,834 and $30,446; allowance for credit losses of $4 and $4) 28,900 29,614
Equity securities 594 229
Premium receivables 8,040 7,902
Self-funded receivables 5,297 4,558
Other receivables 5,881 5,405
Other current assets 6,464 5,795
Assets held for sale 601 0
Total current assets 62,274 60,029
Long-term investments:    
Fixed maturity securities (amortized cost of $867 and $890; allowance for credit losses of $0 and $0) 849 876
Other invested assets 6,810 6,107
Property and equipment, net 4,450 4,359
Goodwill 25,962 25,317
Other intangible assets 10,447 10,273
Other noncurrent assets 2,196 1,967
Total assets 112,988 108,928
Current liabilities:    
Medical claims payable 15,204 16,111
Other policyholder liabilities 4,939 5,600
Unearned income 1,481 1,402
Accounts payable and accrued expenses 5,760 6,910
Short-term borrowings 225 225
Current portion of long-term debt 2,900 1,649
Other current liabilities 11,139 9,894
Liabilities held for sale 165 0
Total current liabilities 41,813 41,791
Long-term debt, less current portion 24,561 23,246
Reserves for future policy benefits 295 778
Deferred tax liabilities, net 2,037 1,970
Other noncurrent liabilities 1,985 1,738
Total liabilities 70,691 69,523
Commitments and contingencies – Note 11
Shareholders’ equity    
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none 0 0
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 231,902,075 and 233,071,088 2 2
Additional paid-in capital 9,001 8,868
Retained earnings 34,575 31,749
Accumulated other comprehensive loss (1,387) (1,313)
Total shareholders’ equity 42,191 39,306
Noncontrolling interests 106 99
Total equity 42,297 39,405
Total liabilities and equity $ 112,988 $ 108,928